Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

786.60INR
22 Jul 2016
Change (% chg)

Rs-7.60 (-0.96%)
Prev Close
Rs794.20
Open
Rs796.00
Day's High
Rs796.00
Day's Low
Rs782.00
Volume
2,552,125
Avg. Vol
3,317,879
52-wk High
Rs966.00
52-wk Low
Rs704.00

SUN.NS

Chart for SUN.NS

About

Sun Pharmaceutical Industries Limited is an India-based generic and pharmaceutical company. The Company's business segments include US Business, which includes Western Europe, Canada, Australia, New Zealand and Other Markets; Indian Branded Generics Business, including Global Consumer Healthcare Business, and Emerging Markets,... (more)

Overall

Beta: 0.32
Market Cap(Mil.): Rs1,893,153.00
Shares Outstanding(Mil.): 2,406.75
Dividend: 1.00
Yield (%): 0.38

Financials

  SUN.NS Industry Sector
P/E (TTM): 40.09 36.47 37.34
EPS (TTM): 19.62 -- --
ROI: 17.49 14.88 14.14
ROE: 16.53 15.96 15.35

BUZZ-India's Sun Pharma down; gains in early trade on share buyback

** Shares of Sun Pharmaceutical Industries rise as much as 1.65 pct in early trade, but down 0.5 pct as of 0552 GMT

24 Jun 2016

India's Sun Pharma enters dermatology segment to expand retail offering

MUMBAI, June 8 India's Sun Pharmaceutical Industries Ltd said on Wednesday it had entered the dermatology segment as part of an initiative to further expand its retail offerings.

08 Jun 2016

Morning News Call - India, June 1

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_06012016.pdf FACTORS TO WATCH 10:30 am: Federal cabinet likely to meet in New Delhi. Agenda not given. GMF: ASIA LIVECHAT - MARKETS FOCUS with Michael Every, Head of Financial Markets Research-Asia-Pacific, Rabobank Lots happening in Asia. While China seems to have cooled down a bit, we have the the BOJ piling on suprises nearly every policy meet. Also

01 Jun 2016

Sun Pharma forecasts annual sales below estimates, shares fall

MUMBAI India's Sun Pharmaceutical Industries Ltd issued a weaker-than expected annual sales outlook as it grapples with increased competition in the United States as well as supply constraints, sending its shares 5 percent lower.

31 May 2016

India's Sun Pharma Q4 profit almost doubles but misses estimates

MUMBAI, May 31 India's largest drugmaker Sun Pharmaceutical Industries Ltd reported a near-doubling in fourth-quarter profit, although that missed analysts' estimates as weakness in emerging markets outweighed higher sales in India and the United States.

31 May 2016

BUZZ-India's Sun Pharma drops; gets U.S. subpoena on generic drug pricing

** India's largest drugmaker says it received a subpoena from the U.S. Department of Justice seeking information about the pricing and marketing of generic drugs it sells in the country

30 May 2016

BUZZ-India's Sun Pharma gains on deal to buy Novartis Japan brands

** India's Sun Pharmaceuticals rises as much as 2.44 pct, set to close higher after two straight days of losses

30 Mar 2016

Sensex posts biggest fall in five weeks

MUMBAI Indian stocks fell more than 1 percent on Monday, posting their biggest single-day fall in five weeks, as investors booked profit in recent outperformers ahead of a busy week of events, including the expiry of domestic derivative contracts.

28 Mar 2016

Indian shares fall 1 pct; metals, drugmakers drag

MUMBAI, March 28 Indian shares fell 1 percent on Monday as investors booked profit in recent outperformers such as State Bank of India and Hindalco Industries ahead of a busy week of events, including the release of U.S. economic data and the expiry of domestic derivative contracts.

28 Mar 2016

BRIEF-Sun Pharma says not looking for external assets as of now

* Dilip Shanghvi says not looking for external assets as of now Further company coverage:

12 Feb 2016

Earnings vs. Estimates